| EAU guidelines on neurogenic lower urinary tract dysfunction M Stöhrer, B Blok, D Castro-Diaz, E Chartier-Kastler, G Del Popolo, ... European urology 56 (1), 81-88, 2009 | 686 | 2009 |
| Efficacy and tolerability of mirabegron, a β3-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European–Australian phase 3 trial V Khullar, G Amarenco, JC Angulo, J Cambronero, K Høye, I Milsom, ... European urology 63 (2), 283-295, 2013 | 550 | 2013 |
| OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a … C Chapple, KD Sievert, S MacDiarmid, V Khullar, P Radziszewski, ... European urology 64 (2), 249-256, 2013 | 436 | 2013 |
| Botulinum toxin a has antinociceptive effects in treating interstitial cystitis CP Smith, P Radziszewski, A Borkowski, GT Somogyi, TB Boone, ... Urology 64 (5), 871-875, 2004 | 329 | 2004 |
| Fournier’s gangrene–current concepts M Wroblewska, B Kuzaka, T Borkowski, P Kuzaka, D Kawecki, ... Polish Journal of Microbiology 63 (3), 267, 2014 | 120 | 2014 |
| Durable efficacy and safety of long-term onabotulinumtoxinA treatment in patients with overactive bladder syndrome: final results of a 3.5-year study VW Nitti, D Ginsberg, KD Sievert, D Sussman, S Radomski, P Sand, ... The Journal of urology 196 (3), 791-800, 2016 | 110 | 2016 |
| OnabotulinumtoxinA improves health-related quality of life in patients with urinary incontinence due to idiopathic overactive bladder: a 36-week, double-blind, placebo … CJ Fowler, S Auerbach, D Ginsberg, D Hale, P Radziszewski, ... European Urology 62 (1), 148-157, 2012 | 101 | 2012 |
| Neurogenic lower urinary tract dysfunction: Clinical management recommendations of the Neurologic Incontinence committee of the fifth International Consultation on Incontinence … MJ Drake, A Apostolidis, A Cocci, A Emmanuel, JB Gajewski, ... Neurourology and urodynamics 35 (6), 657-665, 2016 | 95 | 2016 |
| Neurologic urinary incontinence JJ Wyndaele, A Kovindha, H Madersbacher, P Radziszewski, A Ruffion, ... Neurourology and Urodynamics: Official Journal of the International …, 2010 | 94 | 2010 |
| Safety and tolerability of the β3‐adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12‐week … VW Nitti, CR Chapple, C Walters, MB Blauwet, S Herschorn, I Milsom, ... International journal of clinical practice 68 (8), 972-985, 2014 | 82 | 2014 |
| Guidelines on neurogenic lower urinary tract dysfunction J Pannek, M Stöhrer, B Blok, D Castro-Diaz, G Del Popolo, G Kramer, ... European Association of Urology, 1-64, 2011 | 81 | 2011 |
| Fournier’s gangrene: clinical presentation of 13 cases B Kuzaka, MM Wróblewska, T Borkowski, D Kawecki, P Kuzaka, ... Medical science monitor: international medical journal of experimental and …, 2018 | 80 | 2018 |
| Neurogenic bowel dysfunction: Clinical management recommendations of the Neurologic Incontinence Committee of the Fifth International Consultation on Incontinence 2013 N Cotterill, H Madersbacher, JJ Wyndaele, A Apostolidis, MJ Drake, ... Neurourology and urodynamics 37 (1), 46-53, 2018 | 68 | 2018 |
| Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years MC Michel, P Radziszewski, C Falconer, D Marschall‐Kehrel, K Blot British journal of clinical pharmacology 73 (5), 821-825, 2012 | 60 | 2012 |
| Varicocele as a source of male infertility–current treatment techniques Ł Kupis, PA Dobroński, P Radziszewski Central European journal of urology 68 (3), 365, 2015 | 56 | 2015 |
| Botulinum toxin type A intravesical injections for intractable bladder overactivity P Radziszewski, A Borkowski European Urology Supplements 1 (1), 134, 2002 | 53 | 2002 |
| Neurological urinary and faecal incontinence M Drake, A Apostolidis, A Emmanuel, J Gajewski, S Harrison, ... International Consultation on Incontinence, 2012 | 51 | 2012 |
| Mechanisms of action of botulinum neurotoxins, β3‐adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI … A Kanai, I Zabbarova, M Oefelein, P Radziszewski, Y Ikeda, ... Neurourology and Urodynamics 31 (3), 300-308, 2012 | 48 | 2012 |
| Distribution and neurochemical characterization of sensory dorsal root ganglia neurons supplying porcine urinary bladder A Bossowska, R Crayton, P Radziszewski, Z Kmiec, M Majewski J Physiol Pharmacol 60 (Suppl 4), 77-81, 2009 | 47 | 2009 |
| Treatment of the non-neurogenic storage and voiding disorders with the chemical denervation caused by botulinum toxin type A: a pilot study P Radziszewski Neurourol. Urodyn. 20, 410, 2001 | 42 | 2001 |
